Back to rankings
Hong Kong
3

Capital markets (equity)

Hogan Lovells logo

Hogan Lovells

More information
The capital markets team at Hogan Lovells is well-regarded for its expertise in US and Hong Kong IPOs as well as regulatory and compliance issues. Sammy Li and Nelson Tang spearhead the practice. Li routinely handles IPOs, global offerings, rights issues and other fundraising transactions. Alongside his ECM work, Tang is a key port of call for public takeovers and regulatory issues.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘The team is client-oriented and solution-focused.’

  • ‘Sammy Li brings his commercial and legal expertise to the table, which adds value to the transaction. Sammy can bring his connections with investment banks and make them available to his clients.'

  • ‘The team is highly professional and responsive. They have demonstrated outstanding professionalism in risk prevention and control.'

  • ‘Nelson Tang provides precise guidance at critical moments, strategic thinking to resolve challenges, and is a trustworthy professional. Jeffery Lee is a professional with solid expertise, rigorous and efficient, offering both flexibility and practical advice. Ruby Wang is meticulous and responsible, responsive, communicative, and a strong executive.’

Key clients

  • Chia Tai Enterprises International Limited (Stock Code: 3839)
  • Octillion Energy Holdings, Inc.
  • Shouhui Group Limited
  • China International Capital Corporation Hong Kong Securities Limited
  • Cloudbreak Pharma Inc.
  • E-Star Commercial Management Company Limited (Stock Code: 6668)
  • EKH Pte. Ltd
  • Fineland Real Estate Services Group Limited (stock code: 9978)
  • Guotai Junan Capital Limited
  • Huatai International
  • JY Gas Limited (stock code: 1407)
  • LLJ Phoenix Limited

Work highlights

Advised China International Capital Corporation Hong Kong Securities Limited, the placing agent, on the HK$1.205 billion top-up placing of shares of Sunac China Holdings Limited (HKSE: 1918).
Advised Shouhui Group Limited on its IPO on the Main Board of The Hong Kong Stock Exchange as co-counsel to the issuer.
Advising Cloudbreak Pharma Inc. on its proposed IPO on the Main Board of the Hong Kong Stock Exchange. The Form A1 has been submitted and passed HKSE Listing Committee hearing.

Practice head

Sammy Li; Nelson Tang

Other key lawyers

Jeffrey Lee; Ruby Wang